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ABSTRACT: A supramolecular sensor array composed of two fluorescent cucurbit[n]uril-type
receptors (probe 1 and probe 2) displaying complementary selectivities was tested for its ability
to detect and quantify drug-related amines. The fluorimetric titration of the individual probes
showed highly variable and cross-reactive analyte-dependent changes in fluorescence. An
excellent ability to recognize a variety of analytes was demonstrated in qualitative as well as
quantitative assays. Importantly, a successful quantitative analysis of several analytes of interest
was achieved in mixtures and in human urine. The throughput and sensitivity surpass those of the
current state-of-the-art methods that usually require analyte solid-phase extraction (SPE). These
results open up the opportunity for new applications of cucurbit[n]uril-type receptors in sensing
and pave the way for the development of simple high-throughput assays for various drugs in the
near future.
■ INTRODUCTION
The increasing cost of healthcare and the rising trend of self-
medication drive the increased use of over-the-counter (OTC)
medicines.1 The most popular OTC remedies relieve
symptoms of colds and allergies and associated congestion.2
These OTC remedies typically include analgesics such as
acetaminophen or ibuprofen to relieve pain and sedative
antihistamines such as diphenylhydramine (Benadryl) or
doxylamine (NyQuil) to suppress allergic reactions. Decon-
gestants such as pseudoephedrine or phenylephrine2 and cough
suppressants might also be present. The most common brands
are NyQuil (Vicks), Robitussin (Pfizer), and Sudafed (Johnson
& Johnson), but various store brands are also available. On a
less salubrious level, the ingredients of cold medicines and
antihistamines are psychotropic drugs frequently abused
because of their OTC status.3 An accidental overdose can
lead to death, particularly in children.4
The widespread use of antihistamines and decongestants
with potential for abuse, such as doxylamine, diphenylhydr-
amine, phenylephrine, pseudoephedrine, and dextromethor-
phan, requires that methods for their detection and quantitative
determination are widely available to healthcare professionals,
counselors, and law enforcement. Quantitative determination of
these drugs generally relies on solid-phase extraction (SPE)5
followed by gas chromatography/mass spectrometry (GC/
MS)4,6 or liquid chromatography/mass spectrometry (LC/
MS),7 which are not easily amenable to high-throughput
screening (HTS). A further disadvantage of current urine
analyses is that a number of urine drug tests display cross-
reactivity with antihistamines,8 and as a result, numerous false-
positive urine drug screen (UDS) results are encountered.9
For these reasons, we decided to investigate methods that
could lead to an HTS-amenable assay for addictive components
of OTC medicines. In the broader sense, this problem relates to
the issues associated with analyzing structurally similar
compounds in competitive media and in the presence of
potential interferents.
Here, we focus on a direct method that would not require
prepurification or pre-extraction of the compounds of interest.
We decided to develop an HTS-amenable assay for selected
OTC-available drugs such as antihistamines by exploiting the
supramolecular properties of these analytes, namely, their
ability to undergo protonation while displaying large hydro-
phobic surfaces to be leveraged in hydrophobic interactions
with organic receptors and probes. As receptors, we used
cucurbit[n]uril- (CB[n]-)10 type receptors containing naph-
thalene fluorophores that are amenable to fluorescence-based
reading (Figure 1).
Although cucurbiturils have previously been used in
displacement assays,11 only recently were they found to be
useful in assays based on their intrinsic fluorescence.12 These
probes exhibit unique supramolecular properties enabling
simultaneous sensing of multiple analytes in competitive
media including human urine.
■ RESULTS AND DISCUSSION
Both probes display cross-reactive binding of a number of
amines and ammonium or pyridinium salts. Specifically, probe
1 with a rigid cucurbit[6]uril macrocycle receptor imparts
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selectivity, and acyclic receptor 2 incorporates cross-reactive
binding.13,14 The complementarity of selective and cross-
reactive features enables recognition and quantification of
structurally varied analytes. Both probes contain fluorescent
naphthalene units whose fluorescence is partly quenched by
Eu3+ ions coordinated to CO moieties. This is due to the
energy transfer (antenna effect) from the naphthalene moieties
to the Eu3+ ions. The Eu3+ luminescence is not observed,
however, because of the water molecules coordinated to the
Eu3+ ions.15b The spectral properties of the probe−Eu3+
complex are then modulated upon formation of host−analyte
ensembles. Whether the analytes induce quenching or intensity
amplification of the probe fluorescence depends on the
interplay between the structure, binding mode, and analyte−
receptor affinity.
For example, pyridine (and pyridinium) moieties present in
the analyte, such as paraquat,10 induce quenching of probe
fluorescence. Similarly, depending on the pKa values of their
conjugate acids, aliphatic amines might be able to quench the
naphthalene fluorescence by photoinduced electron transfer
(PET).15 Finally, nitro groups, also known to induce quenching
− add yet another layer of variability in the signal output.
On the other hand, the formation of the complex between a
probe and analyte that does not contain quencher moieties
results in an increase in probe fluorescence. This is presumably
due to the fact that the formation of the complex is associated
with increased rigidity of the receptor and limited rotational/
vibrational modes that would otherwise cause nonradiative
decay. The magnitude of this fluorescence amplification is
therefore intimately related to the drug−probe association
constants and would serve as a fingerprint for the identification
of the analytes.
Taken together, it is clear that OTC-associated medicines
exhibit the structural variability to induce highly variable
responses from the probes. Such responses are likely to be rich
in information and would allow us not only to identify the
OTC-related analytes, but more importantly to quantify them
in aqueous samples. This is of particular interest because of the
well-documented limits of cross-reactive arrays to determine
analyte levels in binary and ternary mixtures.16
The binding of the OTC-available drugs to probes 1 and 2
was confirmed using a combination of mass spectrometry
(Figure 2) and fluorescence titration experiments (Supporting
Information). The two methods independently confirmed
binding of the drugs by the probes. Probe 1 was found to be
more selective than the highly cross-reactive probe 2 (cf. Table
1).
Table 1 shows the binding constants (Kassoc, M
−1) for drugs
used in cold remedies, namely, doxylamine (H1-receptor
antagonist), phenylephrine, pseudoephedrine, and acetamino-
phen. The binding of other histamine antagonists including
famotidine (Pepcid), ranitidine (Zantac), cimetidine (Taga-
met), and nizatidine (Axid) used to block the formation of
peptic ulcers by 1 and 2 was also studied. Importantly, the Kassoc
values in Table 1 suggest that, in the cases where two analytes
Figure 1. Top: Structures of probes 1 and 2. Center: Probes 1 and 2
comprise a cucurbituril-type receptor with naphthalene fluorophores.
Both probes are shown as complexes with histamine. Curbit[6]uril-
derived probe 1 binds smaller analytes, whereas acyclic probe 2 adapts
its size to a wider variety of analytes. Bottom: Analytes associated with
over-the-counter cold remedies such as NyQuil.
Figure 2. (A) MALDI TOF mass spectrum of the complex of 2 and
famotidine. Inset: Calculated isotope pattern for C70H87N22O24S6
+. (B)
ESI mass spectrum of the complex of 2 and doxylamine. Inset:
Calculated isotope pattern for C79H92N18O25S4
2−.
Table 1. Association Constants (Kassoc, M
−1)a Obtained from
Fluorescence Titration and Magnitudes of the Fluorescence
Response (Isat/I0) and the Corresponding Lookup Table
(LUT) for Comparison
aTitrations were recorded in the presence of Eu3+ (300 μM),17 and
Kassoc values were calculated based on the change in fluorescence
intensity upon addition of each guest (pH 3 in water). The errors of
the curve fitting were <18%. bKassoc could not be calculated.
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elicit similar signals, the Kassoc values are different, thus enabling
a reliable recognition. For example, both doxylamine and
acetaminophen induce quenching in both probes 1 and 2.
However, acetaminophen is bound by probe 2 with significantly
lower affinity (Kassoc ≈ 1100 M−1) than doxylamine (Kassoc ≈
105 M−1). This is important because acetaminophen is present
in OTC medicines at higher concentrations than, for example,
doxylamine.
Equally important are the two columns on the right (Table
1) that show the fluorescence response to the presence of
drugs. The color coding of the response magnitude shows that
the responses are specific for each analyte. In combination with
pattern recognition methods,13 the analyte responses enable
correct identification of the analytes even in situations where
the binding affinities are similar.
Figure 3 shows the recognition of cold remedies, their
components, and several antihistamines by probes 1 and 2
using pattern recognition (linear discriminant analysis, LDA).18
The ability to correctly classify all analytes was tested by the
leave-one-out routine (100% correct classification). Here, OTC
cold remedies (NyQuil D, NyQuil Cough, DayQuil) cluster
together, and so do their components. Within these groupings,
the individual clusters are well-resolved. This is of particular
interest because, for example, phenylephrine and pseudoephe-
drine are structurally very similar, and yet they are resolved.
Inspection of the binding constants for phenylephrine and
pseudoephedrine in Table 1 suggests that this resolution is
most likely due to the fact that probe 1 binds phenylephrine
with only marginal affinity.
After we had verified that a small sensor array comprising
only two probes is capable of recognition of the studied
analytes, we explored the quantitative determination of
mixtures of doxylamine (0−22 ppm), pseudoephedrine (0−
27 ppm), and phenylephrine (0−27 ppm). This combination of
a sedative antihistamine (doxylamine) and the decongestant
pseudoephedrine is frequently used in OTC medicationsand
abused. We were interested in investigating whether these
structurally similar amines (particularly pseudoephedrine and
phenylephrine) could be quantitatively analyzed in mixtures at
concentrations relevant to pharmaceutical use. A simultaneous
quantitative analysis of ternary mixtures is difficult12b,16 and, to
the best of our knowledge, has never been accomplished in a
simple cross-reactive array in a competitive medium.
First, we prepared doxylamine (DOX)−pseudoephedrine
(PSE)−phenylephrine (PE) ternary mixtures in pure water in a
way that the concentrations of DOX and PSE were increasing
(from 0 to 22 ppm and from 0 to 26 ppm, respectively) as the
concentration of PE was decreasing (from 27 to 0 ppm). For
each mixture, 20 repetitions were measured, and the standard
deviation (<6%) was calculated. First, an LDA was performed
to provide insight into the clustering and progression of the
changes in the sensor response. LDA (Figure 4) yielded a
smooth trend in the data, clear separation of the clusters, and
100% correct classification of the individual ternary mixtures.
To be able to determine the concentration of each of the
three components independently, we performed regression
analysis for DOX, PSE, and PE. A support vector machine
(SVM) algorithm was used.12b,19 Toward that end, we divided
the acquired data set into two parts, one for calibration and
model development and a second to be used as unknown
samples for cross-validation. Thus, for all three analytes
independently, two concentrations of nine (22% of the overall
data set) were analyzed as unknown concentrations, and the
developed model that describes the behavior of the data was
used to calculate the corresponding concentrations. Here, the
two-probe array yielded a very accurate quantitative regression
analysis of the ternary mixtures (Figure 5). Figure 5 also shows
the correctly quantified two unknown samples (red circles).
Limits of detections (LOD) were determined as 1.0 ppm for
DOX, 0.7 ppm for PSE, and 0.8 ppm for PE.
In practice, doxylamine and other potential drugs of abuse
are usually determined in urine. Human urine is a complex
medium comprising electrolytes, small molecules (urea,
aminoacids, hormones, etc.), and up to 1500 different proteins.
Because doxylamine shows cross-reactivity with drugs of abuse
such as methadone during routine urinalysis, we were
interested in direct urinalysis, namely, without solid-phase
extraction. Incubation of doxylamine with diluted whole human
urine followed by analysis showed a clear dependence on the
sensor fluorescence on the concentration of added DOX
(Figure 6). Corresponding linear regression also enables the
Figure 3. Top: Structures of antihistamines and cold remedies.
Bottom: Linear discriminant analysis (LDA) plot for antihistamines.
Vicks NyQuil and DayQuil cold remedies (Quil cluster) and their
components (Quil components) show 100% correct recognition using
probes 1 and 2 in water ([host] = 12 μM, [guest] = 50 μM, pH 3 and
5).
Figure 4. Linear discriminant analysis (LDA) of ternary mixtures of
doxylamine (DOX), pseudoephedrine (PSE), and phenylephrine (PE)
shows perfect separation of the mixtures depending on their
composition.
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determination of unknown samples (Figure 6 bottom). This
experiment confirmed that doxylamine can be quantified in
urine (LOD = 1.0 ppm, which is lower than that reported using
SPE and GC/MS).20
Finally, we decided to assay the presence of doxylamine and
its two main metabolites (desmethyldoxylamine and didesme-
thyldoxylamine)21 in urine following the ingestion of NyQuil.
Such an experiment is complicated by the highly variable urine
matrix, where the concentrations of urine components change
during the day as a result of food and beverage intake. In our
experiment, a properly hydrated volunteer ingested the
manufacturer-recommended amount of NyQuil Cold & Flu
(30 mL); urine samples were collected before administration
and 1, 3, 5, 6, and 8 h after administration and analyzed by a
hospital laboratory for levels of electrolytes, protein, and
creatinine. The electrolyte values were found to vary
significantly. For example, chloride levels were 10−61 mM;
sodium, 12−62 mM; and potassium, 6−17 mM (see
Supporting Information for details). Interestingly, regardless
of the electrolyte fluctuations, the probe array yielded a clear
trend in response (Figure 7).
The doxylamine urinalysis showed a temporal dependence,
with an extremum at 6 h after ingestion of the medication
followed by an onset of a slow return toward the zero-hour
state (Figure 7). To show that this pattern is due to the
doxylamine and its structurally similar metabolites, we added
pure doxylamine to two urine samples. The purpose for the
introduction of these two spiked samples (labeled with a
yellow-red arrow in Figure 7) was to see whether these artificial
samples would lie within the same trend as the rest of the data.
As expected, the responses from both artificially enriched
samples fell well within the pattern defined by the authentic
samples. This is a strong indication that the array responds to
doxylamine and its two main metabolites. Notably, the array is
not sensitive to fluctuations in salt concentrations, which is
important for clinical application.
■ CONCLUSIONS
In summary, we have demonstrated a simple cross-reactive
sensor array based on two cucurbituril probes to recognize
drug-related amines with known potential for abuse. The
corresponding assay enables rapid analysis of compounds such
as doxylamine, pseudoephedrine, and others in a high-
throughput fashion. The throughput, sensitivity, and LOD
surpass those of the current methods that generally require
analyte extraction.5
Specifically, we demonstrated that several histamine
antagonists and cold remedies such as the antihistamine
sedative doxylamine, pseudoephedrine, and phenylephrine are
successfully recognized by probes 1 and 2 and can be analyzed
Figure 5. Results of simultaneous quantitative analysis of doxylamine
(DOX), pseudoephedrine (PSE), and phenylephrine (PE) mixtures.
Linear regression using a support vector machine (SVM)19 affords
quantitative analysis of DOX, PSE, and PE in the ternary mixtures.
The plots of actual vs predicted concentrations show high accuracy of
prediction for multiple guest concentrations. The root-mean-square
errors (RMSEs) of calibration (C), cross-validation (CV), and
prediction (P) attest to the quality of the model and prediction.
Two unknown samples (red circles) were simultaneously correctly
analyzed.
Figure 6. Results of quantitative analysis of doxylamine in urine using
a sensor array containing probes 1 and 2. Top: Array response
represented by canonical factor F1 (LDA) vs doxylamine concen-
trations in the range of 0−21 ppm (LOD = 1.0 ppm). Bottom: Results
of linear regression for doxylamine in urine. The prediction plots and
the root-mean-square errors (RMSEs) attest to the high quality of the
model and predictions for the unknowns.
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by the corresponding array. Furthermore, these drugs can be
quantitatively analyzed within binary and ternary mixtures and
even in human urine, which is, to the best of our knowledge, a
first. Finally, doxylamine, a drug known to show cross-reactivity
with important drugs of abuse such as methadone during
routine urinalysis, was analyzed in urine. Likewise, urine
samples after NyQuil ingestion displaying various concen-
trations of doxylamine were successfully quantified. Overall,
these results showed that probe arrays comprising fluorescent
cucurbit[n]uril derivatives and acyclic CB[n]-type receptors are
well suited for the development of high-throughput assays for a
wide variety of drugs and have potentially high impact in high-
throughput clinical care settings.
■ ASSOCIATED CONTENT
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Fluorescence spectra, experimental detail of microarray,
canonical score plots, and jackknifed classification matrices.
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